That research is starting to pay off as the companies now look ahead to pivotal studies testing that compound in several Orphazyme has fresh cash from the sale of shares in the US and Europe, which will support its lead rare disease drug through regulatory review and, if approved, a launch. But the drug fell short in key clinical trial measures, raising Now the company is aiming to raise about that amount Had things turned out differently, scientists at Galecto might be watching their idiopathic pulmonary fibrosis drug candidate develop in the hands of a big pharmaceutical company.
But Bristol Myers Squibb passed on its option to acquire Galecto leaving the biotech to In biotech, you can go home again. Four years ago, Illumina spun out cancer diagnostics startup Grail.
Grail set out with the Combined Therapeutics Inc CTx is an early stage startup developing next generation virotherapies targeted with nucleic acids. The pre-clinical biotech aims to Many drugs work by binding to a protein and blocking it. Technology for eliminating disease-causing proteins altogether remains experimental, but this approach has gained ground in the past year with hundreds of millions of dollars raised and compounds advanced into clinical This year we received over nominations across 10 award categories.
Each nomination was carefully reviewed and ranked by the Xconomy editorial staff yielding 40 finalists. All have made unique, game-changing contributions that improve Amyotrophic lateral sclerosis ALS has no cure and few available treatments but the past decade has revealed new knowledge about the pathology of the disease.
The drug, semorinemab, Xconomy is a registered service mark of Xconomy, Inc. All rights reserved. Top Stories. Latest Posts. Congratulations to all the finalists and winners! Xconomy Insight.
Startups Life Sciences. Prior to Business Week, Mr. He was also a National Magazine Award finalist. Carey has degrees in biochemistry B. Danielle Piro, Business Development Manager In her previous role as Sales Manager for Paybefore, Danielle worked with payments technology innovators to create sponsorship packages that maximize their exposure.
She has a wealth of experience in digital media sales and events, previously serving as a senior account executive at Netted by The Webbys, which reports on the best sites, apps and connected products.
Cheryl Wall, Business Development Manager Cheryl joins Xconomy after working as publisher and sales director for BioTechniques, which produces news features and peer-reviewed articles focusing on the latest in methods and techniques for lab scientists and connects product and service providers to lab researchers.
Prior to that she was a sales manager for Pharmaceutical Technology. Erica Feinberg, Head of Event and Content Strategy Erica is a communications specialist with a decade of experience in the life sciences industry. She joins Xconomy from another division of Informa where she was a Conference Producer on global events. Prior to her roles at InformaConnect, Erica was Director of Events at MassBio, where she collaborated with biotech, pharmaceutical, and academic professionals and institutions for program development.
Erica brings her experience of project management to the team at Xconomy to continue to deliver live programs and digital products to the biopharma community. Jamie Gulden, Senior Operations Manager Jamie has over 20 years of management and event planning experience.
Before taking on the event management industry in , she was the owner and chef of her own restaurant in Florida. She brings her extensive experience in event logistics and event planning to the Xconomy team to execute all events. In her free time she enjoys creating art and live music. Nate Leskovic, Senior Marketing Specialist Nate spent a number of years as a newspaper and magazine editor and reporter, covering mostly politics and music, before moving into marketing and communications work.
He was most recently at Primary Care Progress, a healthcare company focused on advocating for and strengthening the primary care system. Christina Nessralla, Operations Coordinator Christina joins Xconomy after working for over three years at Bridgewater State University as Event Technology Supervisor for University Events, helping plan, coordinate, and host all internal and external events for the university campus. From event coordination to event logistics, she brings a wealth of experience in the events industry.
Prior to Sloan, he was a cofounder and the Chief Architect of Swapthing. Andrew earned a B. Our editorial principles are old-fashioned and simple. We believe that our content is only of value to our audience if we ensure that it is trustworthy.
0コメント